ArticleJournal of controlled release : official journal of the Controlled Release Society2015

Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.

Huizi Sha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.